Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-LIMPII/SR-B2 Antibody-APC (7J773)
🥰Excellent
Catalog No. TMAY-03063A
Anti-LIMPII/SR-B2 Antibody-APC (7J773) is a APC-conjugated Rabbit antibody targeting LIMPII/SR-B2. Anti-LIMPII/SR-B2 Antibody-APC (7J773) can be used in FCM.
Anti-LIMPII/SR-B2 Antibody-APC (7J773)
Anti-LIMPII/SR-B2 Antibody-APC (7J773)
🥰Excellent
Catalog No. TMAY-03063A
Anti-LIMPII/SR-B2 Antibody-APC (7J773) is a APC-conjugated Rabbit antibody targeting LIMPII/SR-B2. Anti-LIMPII/SR-B2 Antibody-APC (7J773) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-LIMPII/SR-B2 Antibody-APC (7J773) is a APC-conjugated Rabbit antibody targeting LIMPII/SR-B2. Anti-LIMPII/SR-B2 Antibody-APC (7J773) can be used in FCM. |
| Ig Type | Monoclonal Rabbit IgG |
| Clone | 7J773 |
| Reactivity | Mouse |
| Verified Activity | Flow cytometric analysis of Mouse SCARB2 expression in spleen lymphocytes. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), and then stained with APC Rabbit anti-Mouse SCARB2. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse LIMP-2 / SCARB2 / CD36L2 (rM LIMP-2 / SCARB2 / CD36L2; TMPY-01434; NP_031670.1; Met1-Thr432) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Lysosomal Integral Membrane Protein II (LIMPII), also known as SCARB2, LPG85, and CD36L2, is a type I II multi-pass membrane glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes on all tissues and cell types so far examined. This protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. LIMPII is identified as a receptor for EV71 (human enterovirus species A, Enterovirus 71) and CVA16 (coxsackievirus A16) which are most frequently associated with hand, foot and mouth disease (HFMD). Expression of human LIMPII enables normally unsusceptible cell lines to support the viruses’ propagation and develop cytopathic effects. In addition, LIMPII also has been shown to bind thrombospondin-1, and may contribute to the pro-adhesive changes of activated platelets during coagulation, and inflammation. Deficiency of the protein in mice impairs cell membrane transport processes and causes pelvic junction obstruction, deafness, and peripheral neuropathy. |
| Conjucates | APC |
| Others Formats | Unconjugated/FITC/PE |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Mouse LIMP-2 / SCARB2 / CD36L2 protein (TMPY-01434) |
| Antigen Species | Mouse |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-LIMPII/SR-B2 Antibody-APC (7J773) | purchase Anti-LIMPII/SR-B2 Antibody-APC (7J773) | Anti-LIMPII/SR-B2 Antibody-APC (7J773) cost | order Anti-LIMPII/SR-B2 Antibody-APC (7J773)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.